1. Home
  2. GKOS vs GNRC Comparison

GKOS vs GNRC Comparison

Compare GKOS & GNRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • GNRC
  • Stock Information
  • Founded
  • GKOS 1998
  • GNRC 1959
  • Country
  • GKOS United States
  • GNRC United States
  • Employees
  • GKOS N/A
  • GNRC N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • GNRC Metal Fabrications
  • Sector
  • GKOS Health Care
  • GNRC Consumer Discretionary
  • Exchange
  • GKOS Nasdaq
  • GNRC Nasdaq
  • Market Cap
  • GKOS 8.4B
  • GNRC N/A
  • IPO Year
  • GKOS 2015
  • GNRC 2010
  • Fundamental
  • Price
  • GKOS $102.04
  • GNRC $127.13
  • Analyst Decision
  • GKOS Strong Buy
  • GNRC Buy
  • Analyst Count
  • GKOS 13
  • GNRC 20
  • Target Price
  • GKOS $161.54
  • GNRC $179.89
  • AVG Volume (30 Days)
  • GKOS 1.0M
  • GNRC 833.0K
  • Earning Date
  • GKOS 04-30-2025
  • GNRC 04-30-2025
  • Dividend Yield
  • GKOS N/A
  • GNRC N/A
  • EPS Growth
  • GKOS N/A
  • GNRC 64.83
  • EPS
  • GKOS N/A
  • GNRC 5.39
  • Revenue
  • GKOS $383,481,000.00
  • GNRC $4,295,834,000.00
  • Revenue This Year
  • GKOS $27.84
  • GNRC $7.10
  • Revenue Next Year
  • GKOS $27.99
  • GNRC $7.09
  • P/E Ratio
  • GKOS N/A
  • GNRC $23.58
  • Revenue Growth
  • GKOS 21.85
  • GNRC 6.79
  • 52 Week Low
  • GKOS $88.16
  • GNRC $125.00
  • 52 Week High
  • GKOS $163.71
  • GNRC $195.94
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 37.88
  • GNRC 37.59
  • Support Level
  • GKOS $98.03
  • GNRC $130.07
  • Resistance Level
  • GKOS $108.62
  • GNRC $138.93
  • Average True Range (ATR)
  • GKOS 3.96
  • GNRC 3.67
  • MACD
  • GKOS 1.87
  • GNRC 0.44
  • Stochastic Oscillator
  • GKOS 47.86
  • GNRC 7.56

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Share on Social Networks: